Several studies have confirmed this observation - they found sensitivity to be greater than in either marker used alone: MMP-7, CCL18 (CC chemokine 18), CCL11 (CC chemokine 11) and CA125 in ovarian cancer (SE in the early stages 94.4%) [46]. Here, MMP7 is linked to ovarian carcinoma.